VII Technologies, Corp is a HealthTech, MedicalTech, FitTech, Robotics, and AI venture studio developing advanced systems that personalize and optimize human performance, mental/cognitive health, and physical health.
Our portfolio includes ONE BioOS, a Biological Operating System that interprets biomarkers, biometric data, lifestyle signals, and performance telemetry through the OPL Engine; PunchNFIT, a patented connected performance gaming platform using intelligent wearable controllers and real-time movement data; ANNA, a governed emotional AI system built around Mirror and Prism reasoning; and HYGENUS, an AI-integrated oral health platform with a provisional patent filing around a cartridge-as-handle delivery system.
VII Technologies focuses on practical commercialization, licensing, strategic partnerships, pilot programs, and applied research collaborations across health, wellness, digital therapeutics, sports performance, oral health, and intelligent consumer devices.
Our mission is to use advanced science and technology to personalize and optimize human performance, mental/cognitive health, and physical health.
VII Technologies’ innovation strategy is to build, protect, and commercialize advanced HealthTech, MedicalTech, FitTech, Robotics, and AI systems that turn scientific insight into practical products, licensing opportunities, and strategic partnerships.
Our approach combines four layers: proprietary intellectual property, applied research, intelligent software infrastructure, and commercialization through pilots, licensing, platform partnerships, and direct-to-market products.
We focus on technologies that connect biological data, behavioral data, biometrics, performance telemetry, and AI reasoning into usable systems for consumers, providers, labs, wellness companies, and enterprise partners. This includes ONE BioOS for biological intelligence and biomarker interpretation, PunchNFIT for connected performance gaming and wearable telemetry, ANNA for governed emotional AI, and HYGENUS for AI-integrated oral health.
Our strategy is not limited to invention. We prioritize market validation, patent and trade-secret protection, scalable software architecture, regulatory awareness, strategic partnerships, and revenue pathways. We seek collaborations with companies, research institutions, manufacturers, healthcare organizations, and innovation partners that can help move these technologies from concept and prototype into commercial deployment.
